- Breaking News San Mateo County ninth-graders struggle to stay fit
- Breaking News Food and wine events
- Breaking News Ask Amy: What To Do When the Doctor Isn t in the House
- Breaking News Ed Blonz: Keep your diet normal pre-surgery
Novartis buys Protez for rights to new antibiotic
0 Comments | AFP, June, 2008
BASLE, Switzerland (AFP) — Swiss pharmaceutical giant Novartis announced on Wednesday it had bought Protez Pharmaceuticals for 100 million dollars (64.8 million euros), thus acquiring the rights to a new antibiotic.
The initial 100-million-dollar payment could be followed by up to another 300 million depending on the performance of PZ-601, the antibiotic developed by Protez.
PZ-601 is currently undergoing phase II tests. Novartis and Protez are hoping it will act as a broad-spectrum antibiotic effective against potentially fatal drug-resistant infections, a growing problem in hospitals.
In its statement, Novartis said that more than 100,000 people were estimated to have died in the US and Europe from problems relating to antibiotic resistance.
© 2008 AFP
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Portfolio forecasting tools: what you need to know
- Personality and organizational citizenship behavior
- Fighting financial reporting fraud
- SAS #82: sword or shield?
- The Middle Management Challenge: Moving From Crisis to Empowerment. - book reviews
- HR is mission critical at the FBI: thirty years of corporate HR experience helps the FBI's new HR chief revamp an organization that is changing to meet the challenges of the post-Sept. 11